Literature DB >> 23057870

Phosphodiesterase isoform-specific expression induced by traumatic brain injury.

Anthony A Oliva1, Yuan Kang, Concepcion Furones, Ofelia F Alonso, Olga Bruno, W Dalton Dietrich, Coleen M Atkins.   

Abstract

Traumatic brain injury (TBI) results in significant inflammation which contributes to the evolving pathology. Previously, we have demonstrated that cyclic AMP (cAMP), a molecule involved in inflammation, is down-regulated after TBI. To determine the mechanism by which cAMP is down-regulated after TBI, we determined whether TBI induces changes in phosphodiesterase (PDE) expression. Adult male Sprague Dawley rats received moderate parasagittal fluid-percussion brain injury (FPI) or sham injury, and the ipsilateral, parietal cortex was analyzed by western blotting. In the ipsilateral parietal cortex, expression of PDE1A, PDE4B2, and PDE4D2, significantly increased from 30 min to 24 h post-injury. PDE10A significantly increased at 6 and 24 h after TBI. Phosphorylation of PDE4A significantly increased from 6 h to 7 days post-injury. In contrast, PDE1B, PD4A5, and PDE4A8 significantly decreased after TBI. No changes were observed with PDE1C, PDE3A, PDE4B1/3, PDE4B4, PDE4D3, PDE4D4, PDE8A, or PDE8B. Co-localization studies showed that PDE1A, PDE4B2, and phospho-PDE4A were neuronally expressed, whereas PDE4D2 was expressed in neither neurons nor glia. These findings suggest that therapies to reduce inflammation after TBI could be facilitated with targeted therapies, in particular for PDE1A, PDE4B2, PDE4D2, or PDE10A.
© 2012 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23057870      PMCID: PMC3514616          DOI: 10.1111/jnc.12049

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  50 in total

1.  STAT3 signaling after traumatic brain injury.

Authors:  Anthony A Oliva; Yuan Kang; Juliana Sanchez-Molano; Concepción Furones; Coleen M Atkins
Journal:  J Neurochem       Date:  2012-01-31       Impact factor: 5.372

2.  Differential distribution of PDE4D splice variant mRNAs in rat brain suggests association with specific pathways and presynaptical localization.

Authors:  Xavier Miró; Silvia Pérez-Torres; Pere Puigdomènech; José M Palacios; Guadalupe Mengod
Journal:  Synapse       Date:  2002-09-15       Impact factor: 2.562

3.  Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling.

Authors:  Yun-Feng Li; Yu-Fang Cheng; Ying Huang; Marco Conti; Steven P Wilson; James M O'Donnell; Han-Ting Zhang
Journal:  J Neurosci       Date:  2011-01-05       Impact factor: 6.167

4.  Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues.

Authors:  Viktor Lakics; Eric H Karran; Frank G Boess
Journal:  Neuropharmacology       Date:  2010-05-21       Impact factor: 5.250

5.  Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B.

Authors:  C D Manning; M Burman; S B Christensen; L B Cieslinski; D M Essayan; M Grous; T J Torphy; M S Barnette
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

6.  Selective induction of cAMP phosphodiesterase PDE4B2 expression in experimental autoimmune encephalomyelitis.

Authors:  Elisabet Reyes-Irisarri; Antonio J Sánchez; Juan Antonio García-Merino; Guadalupe Mengod
Journal:  J Neuropathol Exp Neurol       Date:  2007-10       Impact factor: 3.685

7.  Traumatic brain injury causes a long-lasting calcium (Ca2+)-plateau of elevated intracellular Ca levels and altered Ca2+ homeostatic mechanisms in hippocampal neurons surviving brain injury.

Authors:  David A Sun; Laxmikant S Deshpande; Sompong Sombati; Anya Baranova; Margaret S Wilson; Robert J Hamm; Robert J DeLorenzo
Journal:  Eur J Neurosci       Date:  2008-03-25       Impact factor: 3.386

Review 8.  Modulation of immune response by head injury.

Authors:  Maria Cristina Morganti-Kossmann; Laveniya Satgunaseelan; Nicole Bye; Thomas Kossmann
Journal:  Injury       Date:  2007-11-28       Impact factor: 2.586

9.  Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety.

Authors:  Alex B Burgin; Olafur T Magnusson; Jasbir Singh; Pam Witte; Bart L Staker; Jon M Bjornsson; Margret Thorsteinsdottir; Sigrun Hrafnsdottir; Timothy Hagen; Alex S Kiselyov; Lance J Stewart; Mark E Gurney
Journal:  Nat Biotechnol       Date:  2009-12-27       Impact factor: 54.908

10.  Oxidative stress employs phosphatidyl inositol 3-kinase and ERK signalling pathways to activate cAMP phosphodiesterase-4D3 (PDE4D3) through multi-site phosphorylation at Ser239 and Ser579.

Authors:  Elaine V Hill; Catherine L Sheppard; York-Fong Cheung; Irene Gall; Eberhard Krause; Miles D Houslay
Journal:  Cell Signal       Date:  2006-08-01       Impact factor: 4.315

View more
  17 in total

Review 1.  Phosphodiesterase inhibitors as therapeutics for traumatic brain injury.

Authors:  David J Titus; Anthony A Oliva; Nicole M Wilson; Coleen M Atkins
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

2.  Preclinical Western Blot in the Era of Digital Transformation and Reproducible Research, an Eastern Perspective.

Authors:  Saman Sargolzaei; Ajeet Kaushik; Seyed Soltani; M Hadi Amini; Mohammad Reza Khalghani; Navid Khoshavi; Arman Sargolzaei
Journal:  Interdiscip Sci       Date:  2021-06-02       Impact factor: 2.233

3.  Compartmentalized PDE4A5 Signaling Impairs Hippocampal Synaptic Plasticity and Long-Term Memory.

Authors:  Robbert Havekes; Alan J Park; Rosa E Tolentino; Vibeke M Bruinenberg; Jennifer C Tudor; Yool Lee; Rolf T Hansen; Leonardo A Guercio; Edward Linton; Susana R Neves-Zaph; Peter Meerlo; George S Baillie; Miles D Houslay; Ted Abel
Journal:  J Neurosci       Date:  2016-08-24       Impact factor: 6.167

Review 4.  Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain.

Authors:  Michy P Kelly
Journal:  Cell Signal       Date:  2017-11-23       Impact factor: 4.315

Review 5.  Phosphodiesterase-4 (PDE4) molecular pharmacology and Alzheimer's disease.

Authors:  Mark E Gurney; Emily C D'Amato; Alex B Burgin
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

Review 6.  Treatment of traumatic brain injury with anti-inflammatory drugs.

Authors:  Peter J Bergold
Journal:  Exp Neurol       Date:  2015-06-23       Impact factor: 5.330

7.  Therapeutic efficacy of rolipram delivered by PgP nanocarrier on secondary injury and motor function in a rat TBI model.

Authors:  Christian Macks; Daun Jeong; Jeoung Soo Lee
Journal:  Nanomedicine (Lond)       Date:  2022-02-21       Impact factor: 5.307

8.  Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival.

Authors:  E M Medina-Rodríguez; F J Arenzana; J Pastor; M Redondo; V Palomo; R García de Sola; C Gil; A Martínez; A Bribián; F de Castro
Journal:  Cell Mol Life Sci       Date:  2013-05-10       Impact factor: 9.261

9.  Chronic Cognitive Dysfunction after Traumatic Brain Injury Is Improved with a Phosphodiesterase 4B Inhibitor.

Authors:  David J Titus; Nicole M Wilson; Julie E Freund; Melissa M Carballosa; Kevin E Sikah; Concepcion Furones; W Dalton Dietrich; Mark E Gurney; Coleen M Atkins
Journal:  J Neurosci       Date:  2016-07-06       Impact factor: 6.167

10.  A negative allosteric modulator of PDE4D enhances learning after traumatic brain injury.

Authors:  David J Titus; Nicole M Wilson; Oscar Alcazar; Dale A Calixte; W Dalton Dietrich; Mark E Gurney; Coleen M Atkins
Journal:  Neurobiol Learn Mem       Date:  2017-12-30       Impact factor: 2.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.